Latest news
RiboX Therapeutics Announces FDA IND Clearance for RXIM002, the first Circular RNA-Based in vivo CAR Therapy for Autoimmune Cytopenias - The Manila TimesThe Manila Times · Sat, 08 Aug 2026 08:04:32 GMTCircular RNAs offer new pathways to reduce cancer therapy side-effects - News-MedicalNews-Medical · Thu, 06 Aug 2026 09:56:00 GMTCircular RNA discoveries uncover pathways to reduce cancer treatment toxicity - Bioengineer.orgBioengineer.org · Wed, 05 Aug 2026 22:13:47 GMTJ&J pays Sail $785M, charting course to possible in vivo CAR-T buyout - Fierce BiotechFierce Biotech · Thu, 30 Jul 2026 07:00:00 GMT